Global Infectious Diseases In Vitro Diagnostics Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 23 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Infectious Diseases In Vitro Diagnostics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Infectious Diseases In Vitro Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Infectious Diseases In Vitro Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infectious Diseases In Vitro Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Infectious Diseases In Vitro Diagnostics total market, 2018-2029, (USD Million)
Global Infectious Diseases In Vitro Diagnostics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Infectious Diseases In Vitro Diagnostics total market, key domestic companies and share, (USD Million)
Global Infectious Diseases In Vitro Diagnostics revenue by player and market share 2018-2023, (USD Million)
Global Infectious Diseases In Vitro Diagnostics total market by Type, CAGR, 2018-2029, (USD Million)
Global Infectious Diseases In Vitro Diagnostics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Infectious Diseases In Vitro Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott, Alere, Quidel, F. Hoffmann-La Roche, Orasure Technologies, Cepheid, Hologic and Qiagen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infectious Diseases In Vitro Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Infectious Diseases In Vitro Diagnostics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Infectious Diseases In Vitro Diagnostics Market, Segmentation by Type
    MRSA
    Streptococcus
    TB and Drug-resistant TB
    Gastro-intestinal Panel Testing
    HIV
    Hepatitis C
    Others

Global Infectious Diseases In Vitro Diagnostics Market, Segmentation by Application
    Immunochemistry
    Molecular Diagnostics
    Microbiology
    Others

Companies Profiled:
    BD
    Abbott
    Alere
    Quidel
    F. Hoffmann-La Roche
    Orasure Technologies
    Cepheid
    Hologic
    Qiagen
    Bio-Rad Laboratories
    Siemens Healthcare

Key Questions Answered
1. How big is the global Infectious Diseases In Vitro Diagnostics market?
2. What is the demand of the global Infectious Diseases In Vitro Diagnostics market?
3. What is the year over year growth of the global Infectious Diseases In Vitro Diagnostics market?
4. What is the total value of the global Infectious Diseases In Vitro Diagnostics market?
5. Who are the major players in the global Infectious Diseases In Vitro Diagnostics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Infectious Diseases In Vitro Diagnostics Introduction
    1.2 World Infectious Diseases In Vitro Diagnostics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Infectious Diseases In Vitro Diagnostics Total Market by Region (by Headquarter Location)
        1.3.1 World Infectious Diseases In Vitro Diagnostics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Infectious Diseases In Vitro Diagnostics Market Size (2018-2029)
        1.3.3 China Infectious Diseases In Vitro Diagnostics Market Size (2018-2029)
        1.3.4 Europe Infectious Diseases In Vitro Diagnostics Market Size (2018-2029)
        1.3.5 Japan Infectious Diseases In Vitro Diagnostics Market Size (2018-2029)
        1.3.6 South Korea Infectious Diseases In Vitro Diagnostics Market Size (2018-2029)
        1.3.7 ASEAN Infectious Diseases In Vitro Diagnostics Market Size (2018-2029)
        1.3.8 India Infectious Diseases In Vitro Diagnostics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Infectious Diseases In Vitro Diagnostics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Infectious Diseases In Vitro Diagnostics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029)
    2.2 World Infectious Diseases In Vitro Diagnostics Consumption Value by Region
        2.2.1 World Infectious Diseases In Vitro Diagnostics Consumption Value by Region (2018-2023)
        2.2.2 World Infectious Diseases In Vitro Diagnostics Consumption Value Forecast by Region (2024-2029)
    2.3 United States Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029)
    2.4 China Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029)
    2.5 Europe Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029)
    2.6 Japan Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029)
    2.7 South Korea Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029)
    2.8 ASEAN Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029)
    2.9 India Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029)

3 World Infectious Diseases In Vitro Diagnostics Companies Competitive Analysis
    3.1 World Infectious Diseases In Vitro Diagnostics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Infectious Diseases In Vitro Diagnostics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Infectious Diseases In Vitro Diagnostics in 2022
        3.2.3 Global Concentration Ratios (CR8) for Infectious Diseases In Vitro Diagnostics in 2022
    3.3 Infectious Diseases In Vitro Diagnostics Company Evaluation Quadrant
    3.4 Infectious Diseases In Vitro Diagnostics Market: Overall Company Footprint Analysis
        3.4.1 Infectious Diseases In Vitro Diagnostics Market: Region Footprint
        3.4.2 Infectious Diseases In Vitro Diagnostics Market: Company Product Type Footprint
        3.4.3 Infectious Diseases In Vitro Diagnostics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Infectious Diseases In Vitro Diagnostics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Infectious Diseases In Vitro Diagnostics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Infectious Diseases In Vitro Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Infectious Diseases In Vitro Diagnostics Consumption Value Comparison
        4.2.1 United States VS China: Infectious Diseases In Vitro Diagnostics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Infectious Diseases In Vitro Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Infectious Diseases In Vitro Diagnostics Companies and Market Share, 2018-2023
        4.3.1 United States Based Infectious Diseases In Vitro Diagnostics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Infectious Diseases In Vitro Diagnostics Revenue, (2018-2023)
    4.4 China Based Companies Infectious Diseases In Vitro Diagnostics Revenue and Market Share, 2018-2023
        4.4.1 China Based Infectious Diseases In Vitro Diagnostics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Infectious Diseases In Vitro Diagnostics Revenue, (2018-2023)
    4.5 Rest of World Based Infectious Diseases In Vitro Diagnostics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Infectious Diseases In Vitro Diagnostics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Infectious Diseases In Vitro Diagnostics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Infectious Diseases In Vitro Diagnostics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 MRSA
        5.2.2 Streptococcus
        5.2.3 TB and Drug-resistant TB
        5.2.4 Gastro-intestinal Panel Testing
        5.2.5 HIV
        5.2.6 Hepatitis C
        5.2.7 Others
    5.3 Market Segment by Type
        5.3.1 World Infectious Diseases In Vitro Diagnostics Market Size by Type (2018-2023)
        5.3.2 World Infectious Diseases In Vitro Diagnostics Market Size by Type (2024-2029)
        5.3.3 World Infectious Diseases In Vitro Diagnostics Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Infectious Diseases In Vitro Diagnostics Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Immunochemistry
        6.2.2 Molecular Diagnostics
        6.2.3 Microbiology
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Infectious Diseases In Vitro Diagnostics Market Size by Application (2018-2023)
        6.3.2 World Infectious Diseases In Vitro Diagnostics Market Size by Application (2024-2029)
        6.3.3 World Infectious Diseases In Vitro Diagnostics Market Size by Application (2018-2029)

7 Company Profiles
    7.1 BD
        7.1.1 BD Details
        7.1.2 BD Major Business
        7.1.3 BD Infectious Diseases In Vitro Diagnostics Product and Services
        7.1.4 BD Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 BD Recent Developments/Updates
        7.1.6 BD Competitive Strengths & Weaknesses
    7.2 Abbott
        7.2.1 Abbott Details
        7.2.2 Abbott Major Business
        7.2.3 Abbott Infectious Diseases In Vitro Diagnostics Product and Services
        7.2.4 Abbott Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Abbott Recent Developments/Updates
        7.2.6 Abbott Competitive Strengths & Weaknesses
    7.3 Alere
        7.3.1 Alere Details
        7.3.2 Alere Major Business
        7.3.3 Alere Infectious Diseases In Vitro Diagnostics Product and Services
        7.3.4 Alere Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Alere Recent Developments/Updates
        7.3.6 Alere Competitive Strengths & Weaknesses
    7.4 Quidel
        7.4.1 Quidel Details
        7.4.2 Quidel Major Business
        7.4.3 Quidel Infectious Diseases In Vitro Diagnostics Product and Services
        7.4.4 Quidel Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Quidel Recent Developments/Updates
        7.4.6 Quidel Competitive Strengths & Weaknesses
    7.5 F. Hoffmann-La Roche
        7.5.1 F. Hoffmann-La Roche Details
        7.5.2 F. Hoffmann-La Roche Major Business
        7.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product and Services
        7.5.4 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 F. Hoffmann-La Roche Recent Developments/Updates
        7.5.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    7.6 Orasure Technologies
        7.6.1 Orasure Technologies Details
        7.6.2 Orasure Technologies Major Business
        7.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Product and Services
        7.6.4 Orasure Technologies Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Orasure Technologies Recent Developments/Updates
        7.6.6 Orasure Technologies Competitive Strengths & Weaknesses
    7.7 Cepheid
        7.7.1 Cepheid Details
        7.7.2 Cepheid Major Business
        7.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Product and Services
        7.7.4 Cepheid Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Cepheid Recent Developments/Updates
        7.7.6 Cepheid Competitive Strengths & Weaknesses
    7.8 Hologic
        7.8.1 Hologic Details
        7.8.2 Hologic Major Business
        7.8.3 Hologic Infectious Diseases In Vitro Diagnostics Product and Services
        7.8.4 Hologic Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Hologic Recent Developments/Updates
        7.8.6 Hologic Competitive Strengths & Weaknesses
    7.9 Qiagen
        7.9.1 Qiagen Details
        7.9.2 Qiagen Major Business
        7.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Product and Services
        7.9.4 Qiagen Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Qiagen Recent Developments/Updates
        7.9.6 Qiagen Competitive Strengths & Weaknesses
    7.10 Bio-Rad Laboratories
        7.10.1 Bio-Rad Laboratories Details
        7.10.2 Bio-Rad Laboratories Major Business
        7.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product and Services
        7.10.4 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Bio-Rad Laboratories Recent Developments/Updates
        7.10.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
    7.11 Siemens Healthcare
        7.11.1 Siemens Healthcare Details
        7.11.2 Siemens Healthcare Major Business
        7.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product and Services
        7.11.4 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Siemens Healthcare Recent Developments/Updates
        7.11.6 Siemens Healthcare Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Infectious Diseases In Vitro Diagnostics Industry Chain
    8.2 Infectious Diseases In Vitro Diagnostics Upstream Analysis
    8.3 Infectious Diseases In Vitro Diagnostics Midstream Analysis
    8.4 Infectious Diseases In Vitro Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Infectious Diseases In Vitro Diagnostics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Infectious Diseases In Vitro Diagnostics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Infectious Diseases In Vitro Diagnostics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Infectious Diseases In Vitro Diagnostics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Infectious Diseases In Vitro Diagnostics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Infectious Diseases In Vitro Diagnostics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Infectious Diseases In Vitro Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Infectious Diseases In Vitro Diagnostics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Infectious Diseases In Vitro Diagnostics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Infectious Diseases In Vitro Diagnostics Players in 2022
    Table 12. World Infectious Diseases In Vitro Diagnostics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Infectious Diseases In Vitro Diagnostics Company Evaluation Quadrant
    Table 14. Head Office of Key Infectious Diseases In Vitro Diagnostics Player
    Table 15. Infectious Diseases In Vitro Diagnostics Market: Company Product Type Footprint
    Table 16. Infectious Diseases In Vitro Diagnostics Market: Company Product Application Footprint
    Table 17. Infectious Diseases In Vitro Diagnostics Mergers & Acquisitions Activity
    Table 18. United States VS China Infectious Diseases In Vitro Diagnostics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Infectious Diseases In Vitro Diagnostics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Infectious Diseases In Vitro Diagnostics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Infectious Diseases In Vitro Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Infectious Diseases In Vitro Diagnostics Revenue Market Share (2018-2023)
    Table 23. China Based Infectious Diseases In Vitro Diagnostics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Infectious Diseases In Vitro Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Infectious Diseases In Vitro Diagnostics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Infectious Diseases In Vitro Diagnostics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Infectious Diseases In Vitro Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Infectious Diseases In Vitro Diagnostics Revenue Market Share (2018-2023)
    Table 29. World Infectious Diseases In Vitro Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Infectious Diseases In Vitro Diagnostics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Infectious Diseases In Vitro Diagnostics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Infectious Diseases In Vitro Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Infectious Diseases In Vitro Diagnostics Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Infectious Diseases In Vitro Diagnostics Market Size by Application (2024-2029) & (USD Million)
    Table 35. BD Basic Information, Area Served and Competitors
    Table 36. BD Major Business
    Table 37. BD Infectious Diseases In Vitro Diagnostics Product and Services
    Table 38. BD Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. BD Recent Developments/Updates
    Table 40. BD Competitive Strengths & Weaknesses
    Table 41. Abbott Basic Information, Area Served and Competitors
    Table 42. Abbott Major Business
    Table 43. Abbott Infectious Diseases In Vitro Diagnostics Product and Services
    Table 44. Abbott Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Abbott Recent Developments/Updates
    Table 46. Abbott Competitive Strengths & Weaknesses
    Table 47. Alere Basic Information, Area Served and Competitors
    Table 48. Alere Major Business
    Table 49. Alere Infectious Diseases In Vitro Diagnostics Product and Services
    Table 50. Alere Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Alere Recent Developments/Updates
    Table 52. Alere Competitive Strengths & Weaknesses
    Table 53. Quidel Basic Information, Area Served and Competitors
    Table 54. Quidel Major Business
    Table 55. Quidel Infectious Diseases In Vitro Diagnostics Product and Services
    Table 56. Quidel Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Quidel Recent Developments/Updates
    Table 58. Quidel Competitive Strengths & Weaknesses
    Table 59. F. Hoffmann-La Roche Basic Information, Area Served and Competitors
    Table 60. F. Hoffmann-La Roche Major Business
    Table 61. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product and Services
    Table 62. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. F. Hoffmann-La Roche Recent Developments/Updates
    Table 64. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
    Table 65. Orasure Technologies Basic Information, Area Served and Competitors
    Table 66. Orasure Technologies Major Business
    Table 67. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product and Services
    Table 68. Orasure Technologies Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Orasure Technologies Recent Developments/Updates
    Table 70. Orasure Technologies Competitive Strengths & Weaknesses
    Table 71. Cepheid Basic Information, Area Served and Competitors
    Table 72. Cepheid Major Business
    Table 73. Cepheid Infectious Diseases In Vitro Diagnostics Product and Services
    Table 74. Cepheid Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Cepheid Recent Developments/Updates
    Table 76. Cepheid Competitive Strengths & Weaknesses
    Table 77. Hologic Basic Information, Area Served and Competitors
    Table 78. Hologic Major Business
    Table 79. Hologic Infectious Diseases In Vitro Diagnostics Product and Services
    Table 80. Hologic Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Hologic Recent Developments/Updates
    Table 82. Hologic Competitive Strengths & Weaknesses
    Table 83. Qiagen Basic Information, Area Served and Competitors
    Table 84. Qiagen Major Business
    Table 85. Qiagen Infectious Diseases In Vitro Diagnostics Product and Services
    Table 86. Qiagen Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Qiagen Recent Developments/Updates
    Table 88. Qiagen Competitive Strengths & Weaknesses
    Table 89. Bio-Rad Laboratories Basic Information, Area Served and Competitors
    Table 90. Bio-Rad Laboratories Major Business
    Table 91. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product and Services
    Table 92. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Bio-Rad Laboratories Recent Developments/Updates
    Table 94. Siemens Healthcare Basic Information, Area Served and Competitors
    Table 95. Siemens Healthcare Major Business
    Table 96. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product and Services
    Table 97. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 98. Global Key Players of Infectious Diseases In Vitro Diagnostics Upstream (Raw Materials)
    Table 99. Infectious Diseases In Vitro Diagnostics Typical Customers
List of Figure
    Figure 1. Infectious Diseases In Vitro Diagnostics Picture
    Figure 2. World Infectious Diseases In Vitro Diagnostics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Infectious Diseases In Vitro Diagnostics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Infectious Diseases In Vitro Diagnostics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Infectious Diseases In Vitro Diagnostics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Infectious Diseases In Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Infectious Diseases In Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Infectious Diseases In Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Infectious Diseases In Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Infectious Diseases In Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Infectious Diseases In Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Infectious Diseases In Vitro Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 13. Infectious Diseases In Vitro Diagnostics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Infectious Diseases In Vitro Diagnostics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Infectious Diseases In Vitro Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Infectious Diseases In Vitro Diagnostics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Infectious Diseases In Vitro Diagnostics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Infectious Diseases In Vitro Diagnostics Markets in 2022
    Figure 27. United States VS China: Infectious Diseases In Vitro Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Infectious Diseases In Vitro Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Infectious Diseases In Vitro Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Infectious Diseases In Vitro Diagnostics Market Size Market Share by Type in 2022
    Figure 31. MRSA
    Figure 32. Streptococcus
    Figure 33. TB and Drug-resistant TB
    Figure 34. Gastro-intestinal Panel Testing
    Figure 35. HIV
    Figure 36. Hepatitis C
    Figure 37. Others
    Figure 38. World Infectious Diseases In Vitro Diagnostics Market Size Market Share by Type (2018-2029)
    Figure 39. World Infectious Diseases In Vitro Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Infectious Diseases In Vitro Diagnostics Market Size Market Share by Application in 2022
    Figure 41. Immunochemistry
    Figure 42. Molecular Diagnostics
    Figure 43. Microbiology
    Figure 44. Others
    Figure 45. Infectious Diseases In Vitro Diagnostics Industrial Chain
    Figure 46. Methodology
    Figure 47. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Infectious Diseases In Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Infectious Diseases In Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Infectious Diseases In Vitro Diagnostics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Infectious Diseases In Vitro Diagnostics

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>